534 results on '"Fremeaux ‐ Bacchi, Veronique"'
Search Results
2. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
3. Thrombotic Microangiopathy as an Emerging Complication of Viral Vector–Based Gene Therapy
4. De novo thrombotic microangiopathy after kidney transplantation in adults: Interplay between complement genetics and multiple endothelial injury
5. Atypical Hemolytic Uremic Syndrome
6. Usefulness and analytical performances of complement multiplex assay for measuring complement biomarkers in plasma
7. Complement in human disease: approved and up-and-coming therapeutics
8. C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features
9. How I diagnose and treat atypical hemolytic uremic syndrome
10. Exome-First Strategy in Adult Patients With CKD: A Cohort Study
11. Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy
12. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series
13. Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy
14. The Rational Use of Complement Inhibitors in Kidney Diseases
15. Les bloqueurs du complément : nouvelles pistes thérapeutiques en néphrologie
16. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
17. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway
18. Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study
19. Ex Vivo Complement Activation on Endothelial Cells: Research and Translational Value
20. Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients
21. Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies
22. Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis
23. Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009- 2017
24. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group
25. Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study
26. Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties
27. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner
28. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors
29. Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome
30. Anti CFH-associated HUS: do we still need Plasma Exchange?
31. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome
32. Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
33. Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies
34. Complement in human disease: approved and up-and-coming therapeutics
35. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series
36. C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
37. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy
38. Haemolytic uraemic syndrome
39. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy
40. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
41. Digital Ischemia as a Rare Manifestation of C3 Glomerulopathy Associated With Monoclonal Gammopathy
42. Atypical Hemolytic Uremic Syndrome
43. Endothelium structure and function in kidney health and disease
44. P392: Rapid complement mediated TMA diagnosis and early intervention in a renal intensive care unit using Nanopore technology
45. Defining the genetics of thrombotic microangiopathies
46. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome
47. Detection of Autoantibodies to Complement Components by Surface Plasmon Resonance-Based Technology
48. Data from Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s
49. Supplementary Tables from Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s
50. Supplementary Figures from Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.